Matches in Wikidata for { <http://www.wikidata.org/entity/Q37265118> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q37265118 description "article científic" @default.
- Q37265118 description "article scientifique" @default.
- Q37265118 description "articolo scientifico" @default.
- Q37265118 description "artigo científico" @default.
- Q37265118 description "artículu científicu espublizáu en 2016" @default.
- Q37265118 description "bilimsel makale" @default.
- Q37265118 description "scientific article published on July 2016" @default.
- Q37265118 description "vedecký článok" @default.
- Q37265118 description "vetenskaplig artikel" @default.
- Q37265118 description "videnskabelig artikel" @default.
- Q37265118 description "vědecký článek" @default.
- Q37265118 description "wetenschappelijk artikel" @default.
- Q37265118 description "wissenschaftlicher Artikel" @default.
- Q37265118 description "наукова стаття, опублікована в липні 2016" @default.
- Q37265118 description "научни чланак" @default.
- Q37265118 description "مقالة علمية نشرت في يوليو 2016" @default.
- Q37265118 name "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 name "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 name "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer." @default.
- Q37265118 type Item @default.
- Q37265118 label "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 label "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 label "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer." @default.
- Q37265118 prefLabel "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 prefLabel "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 prefLabel "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer." @default.
- Q37265118 P1433 Q37265118-A18C1262-4FC3-496A-BFBB-C93ABF0CF3DF @default.
- Q37265118 P1476 Q37265118-20638A01-E72C-47E3-839D-34017A57884C @default.
- Q37265118 P2093 Q37265118-1F8E119B-B71B-46CE-8D74-4276DDEEBBC0 @default.
- Q37265118 P2093 Q37265118-777DCC56-531E-4F1D-B0EB-C672E92D8727 @default.
- Q37265118 P2093 Q37265118-FB4DE40B-4CB4-4278-B7AB-59F8EEB40CCE @default.
- Q37265118 P275 Q37265118-27964C58-0A76-472E-BC14-AD8454395992 @default.
- Q37265118 P2860 Q37265118-082E80F7-38E8-4CFB-890B-560D98440BB6 @default.
- Q37265118 P2860 Q37265118-2B3B30ED-A9EC-4AFA-8B02-E9ED8B6052C4 @default.
- Q37265118 P2860 Q37265118-3FE900C3-E76F-4F78-9164-1817D9F7067A @default.
- Q37265118 P2860 Q37265118-5F2A7BF1-6EEB-46CF-9A7D-45F08364419A @default.
- Q37265118 P2860 Q37265118-750DBBFA-DD18-4A63-9584-199A96929AD6 @default.
- Q37265118 P2860 Q37265118-9198F6CF-E9AB-4BF7-9E5C-75C2AEEC07DB @default.
- Q37265118 P2860 Q37265118-BDEFF91D-1FFD-41C1-802D-C6ABB8492D1D @default.
- Q37265118 P2860 Q37265118-CF38B4A0-3385-43C4-8265-5540BB65918B @default.
- Q37265118 P2860 Q37265118-F409B08D-9F56-4000-9D9C-EE1D41FB9F79 @default.
- Q37265118 P304 Q37265118-A26C505F-9B1E-4925-9B8B-FA21949E0B03 @default.
- Q37265118 P31 Q37265118-2CDD6629-422F-4D94-AD11-2D6D09B7743B @default.
- Q37265118 P31 Q37265118-b19e5690-76cc-4ba1-8b99-c52600841063 @default.
- Q37265118 P356 Q37265118-7FA544B4-1331-464E-8531-B8FD1D09A4DA @default.
- Q37265118 P433 Q37265118-C4809DEB-93EA-49FE-84FC-13EE5F5041D8 @default.
- Q37265118 P478 Q37265118-BB4FEE42-89EC-4B3E-828E-93AB21A1E202 @default.
- Q37265118 P577 Q37265118-3EDF32F8-F787-45A4-ABFD-972A4C64C768 @default.
- Q37265118 P6216 Q37265118-E3CF800D-44F4-40CC-89E2-40E8F4D82A60 @default.
- Q37265118 P698 Q37265118-A7F00CE3-7D13-4219-879F-42E499680369 @default.
- Q37265118 P921 Q37265118-A1429E99-4D0B-4FA3-8948-38A5AB5A3246 @default.
- Q37265118 P921 Q37265118-F81AAF98-1A6B-4DA3-B068-4512974D9065 @default.
- Q37265118 P932 Q37265118-8F9F9772-CB7F-4F3A-A430-998FB236A61F @default.
- Q37265118 P356 0971-5851.190354 @default.
- Q37265118 P698 27688614 @default.
- Q37265118 P1433 Q15710014 @default.
- Q37265118 P1476 "Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer" @default.
- Q37265118 P2093 "Ashish Singh" @default.
- Q37265118 P2093 "Seema Gulia" @default.
- Q37265118 P2093 "Sudeep Gupta" @default.
- Q37265118 P275 Q24082749 @default.
- Q37265118 P2860 Q38099258 @default.
- Q37265118 P2860 Q43079397 @default.
- Q37265118 P2860 Q48341810 @default.
- Q37265118 P2860 Q48555488 @default.
- Q37265118 P2860 Q48704506 @default.
- Q37265118 P2860 Q48887166 @default.
- Q37265118 P2860 Q73829301 @default.
- Q37265118 P2860 Q79080321 @default.
- Q37265118 P2860 Q83204469 @default.
- Q37265118 P304 "196-198" @default.
- Q37265118 P31 Q13442814 @default.
- Q37265118 P31 Q2782326 @default.
- Q37265118 P356 "10.4103/0971-5851.190354" @default.
- Q37265118 P433 "3" @default.
- Q37265118 P478 "37" @default.
- Q37265118 P577 "2016-07-01T00:00:00Z" @default.
- Q37265118 P6216 Q50423863 @default.
- Q37265118 P698 "27688614" @default.
- Q37265118 P921 Q412616 @default.
- Q37265118 P921 Q415271 @default.
- Q37265118 P932 "5027793" @default.